Cargando…

Novel Tetrazole-Based Antimicrobial Agents Targeting Clinical Bacteria Strains: Exploring the Inhibition of Staphylococcus aureus DNA Topoisomerase IV and Gyrase

Eleven novel imide-tetrazoles were synthesized. In the initial stage of research, in silico structure-based pharmacological prediction was conducted. All compounds were screened for antimicrobial activity using standard and clinical strains. Within the studied group, compounds 1–3 were recognized as...

Descripción completa

Detalles Bibliográficos
Autores principales:	Roszkowski, Piotr, Szymańska-Majchrzak, Jolanta, Koliński, Michał, Kmiecik, Sebastian, Wrzosek, Małgorzata, Struga, Marta, Szulczyk, Daniel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8745314/ https://www.ncbi.nlm.nih.gov/pubmed/35008805 http://dx.doi.org/10.3390/ijms23010378

Ejemplares similares

Synthetic Transition from Thiourea-Based Compounds to Tetrazole Derivatives: Structure and Biological Evaluation of Synthesized New N-(Furan-2-ylmethyl)-1H-tetrazol-5-amine Derivatives
por: Szulczyk, Daniel, et al.
Publicado: (2021)

Design and Synthesis of Menthol and Thymol Derived Ciprofloxacin: Influence of Structural Modifications on the Antibacterial Activity and Anticancer Properties
por: Szostek, Tomasz, et al.
Publicado: (2022)

Activities of gyrase and topoisomerase IV on positively supercoiled DNA
por: Ashley, Rachel E., et al.
Publicado: (2017)

Menthol- and thymol-based ciprofloxacin derivatives against Mycobacterium tuberculosis: in vitro activity, lipophilicity, and computational studies
por: Szulczyk, Daniel, et al.
Publicado: (2023)

The Effect of Conjugation of Ciprofloxacin and Moxifloxacin with Fatty Acids on Their Antibacterial and Anticancer Activity
por: Chrzanowska, Alicja, et al.
Publicado: (2022)

Distribution of gyrase and topoisomerase IV on bacterial nucleoid: implications for nucleoid organization
por: Hsu, Ya-Han, et al.
Publicado: (2006)

N-Acylated Ciprofloxacin Derivatives: Synthesis and In Vitro Biological Evaluation as Antibacterial and Anticancer Agents
por: Struga, Marta, et al.
Publicado: (2023)

Developments in Non-Intercalating Bacterial Topoisomerase Inhibitors: Allosteric and ATPase Inhibitors of DNA Gyrase and Topoisomerase IV
por: Grossman, Scott, et al.
Publicado: (2023)

Exploring the Staphylococcus aureus Gyrase Complex and Human Topoisomerase: Potential Target for Molecular Docking and Biological Studies with Substituted Polychloroaniline
por: Tomar, Richa, et al.
Publicado: (2023)

What makes a type IIA topoisomerase a gyrase or a Topo IV?
por: Hirsch, Jana, et al.
Publicado: (2021)

Thiosemicarbazide Derivatives Decrease the ATPase Activity of Staphylococcus aureus Topoisomerase IV, Inhibit Mycobacterial Growth, and Affect Replication in Mycobacterium smegmatis
por: Kowalczyk, Aleksandra, et al.
Publicado: (2021)

Actions of a Novel Bacterial Topoisomerase Inhibitor against Neisseria gonorrhoeae Gyrase and Topoisomerase IV: Enhancement of Double-Stranded DNA Breaks
por: Dauda, Soziema E., et al.
Publicado: (2023)

High-throughput assays for DNA gyrase and other topoisomerases
por: Maxwell, Anthony, et al.
Publicado: (2006)

DNA Gyrase and Topoisomerase IV Mutations and their effect on Quinolones Resistant Proteus mirabilis among UTIs Patients
por: Abdelkreem, Randa H, et al.
Publicado: (2020)

Direct observation of helicase–topoisomerase coupling within reverse gyrase
por: Yang, Xi, et al.
Publicado: (2020)

The balance between gyrase and topoisomerase I activities determines levels of supercoiling, nucleoid compaction, and viability in bacteria
por: García-López, Míriam, et al.
Publicado: (2023)

Cytotoxicity Evaluation of Novel bis(2-aminoethyl)amine Derivatives
por: Szulczyk, Daniel, et al.
Publicado: (2020)

High Resolution Melting Analysis for Rapid Mutation Screening in Gyrase and Topoisomerase IV Genes in Quinolone-Resistant Salmonella enterica
por: Ngoi, Soo Tein, et al.
Publicado: (2014)

Characterization of Mutations in DNA Gyrase and Topoisomerase IV in Field Strains and In Vitro Selected Quinolone-Resistant Mycoplasma hyorhinis Mutants
por: Li, Jun, et al.
Publicado: (2022)

Design, Synthesis, and Antibacterial Screening of Some Novel Heteroaryl-Based Ciprofloxacin Derivatives as DNA Gyrase and Topoisomerase IV Inhibitors
por: Al-Wahaibi, Lamya H., et al.
Publicado: (2021)

Transcription facilitated genome-wide recruitment of topoisomerase I and DNA gyrase
por: Ahmed, Wareed, et al.
Publicado: (2017)

1249. Genetic Evidence That Gepotidacin Shows Well-balanced Dual Targeting against DNA Gyrase And Topoisomerase IV in Neisseria gonorrhoeae
por: Chan, Pan, et al.
Publicado: (2020)

Dual effectiveness of Alternaria but not Fusarium mycotoxins against human topoisomerase II and bacterial gyrase
por: Jarolim, Katharina, et al.
Publicado: (2016)

Novel ciprofloxacin and norfloxacin-tetrazole hybrids as potential antibacterial and antiviral agents: Targeting S. aureus topoisomerase and SARS-CoV-2-MPro
por: Cardoso-Ortiz, Jaime, et al.
Publicado: (2023)

Synthesis, Antimicrobial Activity and Molecular Docking of Novel Thiourea Derivatives Tagged with Thiadiazole, Imidazole and Triazine Moieties as Potential DNA Gyrase and Topoisomerase IV Inhibitors
por: Hashem, Heba E., et al.
Publicado: (2020)

The reverse gyrase helicase-like domain is a nucleotide-dependent switch that is attenuated by the topoisomerase domain
por: del Toro Duany, Yoandris, et al.
Publicado: (2008)

A 2.8 Å Structure of Zoliflodacin in a DNA Cleavage Complex with Staphylococcus aureus DNA Gyrase
por: Morgan, Harry, et al.
Publicado: (2023)

Fic Proteins Inhibit the Activity of Topoisomerase IV by AMPylation in Diverse Bacteria
por: Lu, Can-Hua, et al.
Publicado: (2020)

Functional Analyses of the Toxoplasma gondii DNA Gyrase Holoenzyme: A Janus Topoisomerase with Supercoiling and Decatenation Abilities
por: Lin, Ting-Yu, et al.
Publicado: (2015)

Novel Bacterial Topoisomerase Inhibitors Exploit Asp83 and the Intrinsic Flexibility of the DNA Gyrase Binding Site
por: Franco-Ulloa, Sebastian, et al.
Publicado: (2018)

6-Bromo-2-methylsulfanyl-1,3-benzothiazole
por: Dobrowolski, Michał A., et al.
Publicado: (2011)

Structural insight into negative DNA supercoiling by DNA gyrase, a bacterial type 2A DNA topoisomerase
por: Papillon, Julie, et al.
Publicado: (2013)

Crystallization and preliminary X-ray diffraction analysis of two N-terminal fragments of the DNA-cleavage domain of topoisomerase IV from Staphylococcus aureus
por: Carr, Stephen B., et al.
Publicado: (2006)

The New Face of a Well-Known Antibiotic: A Review of the Anticancer Activity of Enoxacin and Its Derivatives
por: Jałbrzykowska, Karolina, et al.
Publicado: (2022)

Crystallization and preliminary X-ray diffraction analysis of two N-terminal fragments of the DNA-cleavage domain of topoisomerase IV from Staphylococcus aureus. Corrigendum
por: Carr, Stephen B., et al.
Publicado: (2006)

Application of a Novel Microtitre Plate-Based Assay for the Discovery of New Inhibitors of DNA Gyrase and DNA Topoisomerase VI
por: Taylor, James A., et al.
Publicado: (2013)

Synthesis and Biological Evaluation of Novel Indole-Derived Thioureas
por: Sanna, Giuseppina, et al.
Publicado: (2018)

4-(3-Fluorophenyl)-1-(propan-2-ylidene)thiosemicarbazone
por: Miroslaw, Barbara, et al.
Publicado: (2011)

Structure of reverse gyrase with a minimal latch that supports ATP-dependent positive supercoiling without specific interactions with the topoisomerase domain
por: Mhaindarkar, Vaibhav P., et al.
Publicado: (2023)

The Structural Features of Novel Bacterial Topoisomerase Inhibitors That Define Their Activity on Topoisomerase IV
por: Kokot, Maja, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tgf25vabc8mvjavmtgkdc9mklf